Literature DB >> 30548670

Overexpressed circ_0029426 in glioblastoma forecasts unfavorable prognosis and promotes cell progression by sponging miR-197.

Guifang Zhang1, Weibo Sun2, Liangfu Zhu1, Yingpu Feng1, Liheng Wu1, Tianxiao Li1.   

Abstract

Accumulating studies indicates that circular RNAs (circRNAs) play an imperative role in modulating cancer progression and metastasis. In the previous study, elevated circ_0029426 was first observed in glioblastoma (GBM) tissues compared with normal tissues by circRNA microarray. Our aim is to study the function and mechanism of circ_0029426 in GBM. Quantitative reverse transcription polymerase chain reaction was used to detect relative circ_0029426 expression in GBM tissue samples and cells. Fisher's exact test was used to evaluate the expression of circ_0029426 and clinical parameters.The Kaplan-Meier method and Cox regression were analyzed to evaluate the link between circ_0029426 expression and the overall survival of patients with GBM. Loss/gain-of function experiments were performed to measure GBM cell growth, apoptosis, migration, and invasion. Dual luciferase reporter assays were applied to detect the binding ability between circ_0029426 and miR-197. As a result, the circ_0029426 expression is tightly correlated with patients' clinical severity and prognosis. Functionally, circ_0029426 strikingly promoted cell proliferation, migration and invasion, and inhibited cell apoptosis. Mechanistically, miR-197 was predicted and verified to be sponged by circ_0029426. More importantly, the oncogenic functions of circ_0029426 are partially attributed to its suppression on miR-197. Collectively, circ_0029426 may be taken as a potential therapeutic target for GBM.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  circ_0029426; circular RNA (circRNAs); glioblastoma (GBM); miR-197

Year:  2018        PMID: 30548670     DOI: 10.1002/jcb.28313

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Circ_0060055 Promotes the Growth, Invasion, and Radioresistance of Glioblastoma by Targeting MiR-197-3p/API5 Axis.

Authors:  Jinjin Yuan; Zongwen Liu; Junqi Liu; Ruitai Fan
Journal:  Neurotox Res       Date:  2022-07-18       Impact factor: 3.978

Review 2.  The protean world of non-coding RNAs in glioblastoma.

Authors:  Ramasamy Paulmurugan; Meenakshi Malhotra; Tarik F Massoud
Journal:  J Mol Med (Berl)       Date:  2019-05-25       Impact factor: 4.599

3.  Role of CircRNAs_100395 in Proliferation and Metastases of Liver Cancer.

Authors:  Qiaming Chen; Zhian Chen; Sai Cao; Botang Guo; Yilin Chen; Zixin Feng; Jiaqi Wang; Guohu Guo; Xinhua Chen; Xianying Huang
Journal:  Med Sci Monit       Date:  2019-08-17

4.  Molecular network-based identification of competing endogenous RNAs in bladder cancer.

Authors:  Wei-Dong Jiang; Ping-Cheng Yuan
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

5.  Comment on "circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer".

Authors:  Farid Rahimi; Amin Talebi Bezmin Abadi
Journal:  Dis Markers       Date:  2019-09-12       Impact factor: 3.434

6.  Plasmatic circRNA Predicting the Occurrence of Human Glioblastoma.

Authors:  Ainian Chen; Lingling Zhong; Keju Ju; Ting Lu; Jia Lv; Hua Cao
Journal:  Cancer Manag Res       Date:  2020-04-29       Impact factor: 3.989

Review 7.  Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms.

Authors:  Raziyeh Salami; Marziyeh Salami; Alireza Mafi; Omid Vakili; Zatollah Asemi
Journal:  Cell Commun Signal       Date:  2022-01-28       Impact factor: 5.712

Review 8.  Biological Roles and Mechanisms of Circular RNA in Human Cancers.

Authors:  Qing Tang; Swei Sunny Hann
Journal:  Onco Targets Ther       Date:  2020-03-09       Impact factor: 4.147

Review 9.  Circular RNAs: Emerging Role in Cancer Diagnostics and Therapeutics.

Authors:  Anuva Rajappa; Sucharita Banerjee; Vivek Sharma; Piyush Khandelia
Journal:  Front Mol Biosci       Date:  2020-10-28

10.  CircRNAs as potential biomarkers for the clinicopathology and prognosis of glioma patients: a meta-analysis.

Authors:  Xiangqian Ding; Luyao Yang; Xin Geng; Yanghong Zou; Zhigang Wang; Yao Li; Renli Qi; Wei Wang; Jinghui Li; Hualin Yu
Journal:  BMC Cancer       Date:  2020-10-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.